SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-003268
Filing Date
2020-05-29
Accepted
2020-05-29 16:14:36
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 a2241735z424b5.htm 424B5 294892
2 G717743.JPG g717743.jpg GRAPHIC 36281
3 G936442.JPG g936442.jpg GRAPHIC 19417
4 G541111.JPG g541111.jpg GRAPHIC 91661
5 G429354.JPG g429354.jpg GRAPHIC 97794
6 G732609.JPG g732609.jpg GRAPHIC 83680
7 G658271.JPG g658271.jpg GRAPHIC 27211
  Complete submission text file 0001047469-20-003268.txt   787146
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238140 | Film No.: 20927903
SIC: 2834 Pharmaceutical Preparations